Dexmedetomidine as Adjuvant for Bupivacaine in Ultrasound Guided Infraorbital Nerve Block for Cleft Lip Repair

Sponsor
Mansoura University (Other)
Overall Status
Completed
CT.gov ID
NCT03480607
Collaborator
(none)
44
1
2
9.3
4.7

Study Details

Study Description

Brief Summary

To assess the efficacy of dexamethasone versus dexmedetomidine as adjuncts to bupivacaine for infra-orbital nerve block in infants undergoing cleft lip surgery.

Condition or Disease Intervention/Treatment Phase
  • Drug: Dexmedetomidine group
  • Drug: Dexamethasone group
Phase 4

Detailed Description

Regarding patient registry; A prior G power analysis was done. Using the results obtained from previous studies and assuming an alpha error of 0.05 and beta error 0f 0.2 (power of the study 80 %), a sample size of 20 patients per group was calculated. A drop out 10% of cases is expected, so; 22 cases per group will be required.

Statistical analysis: Data will be analyzed through SPSS (Statistical Package for Social Sciences). Program version 22. Distribution of data will be first tested by Shapiro test. Data will be presented as mean and standard deviation (SD), median and range or numbers and percentages. For normally distributed data, unpaired t test will be used to compare between mean values of both groups. For pain and sedation scores, Mann Whitney U test will be used. Fisher's exact test will be used for comparison of categorical data. The P value ≤ 0.05 will be considered as the level of statistical significance.

Study Design

Study Type:
Interventional
Actual Enrollment :
44 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Care Provider)
Primary Purpose:
Supportive Care
Official Title:
Comparative Evaluation of Dexamethasone and Dexmedetomidine as Adjuvants for Bupivacaine in Ultrasound Guided Infraorbital Nerve Block in Infants for Cleft Lip Repair
Actual Study Start Date :
Aug 1, 2017
Actual Primary Completion Date :
Apr 30, 2018
Actual Study Completion Date :
May 10, 2018

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Dexmedetomidine group

Dexmedetomidine in conjunction with bupivacaine for infra-orbital nerve block

Drug: Dexmedetomidine group
0.75 ml of 0.5% Bupivacaine in conjunction with 0.5 mcg/kg dexmedetomidine

Active Comparator: Dexamethasone group

Dexamethasone in conjunction with bupivacaine f

Drug: Dexamethasone group
0.75 ml of 0.5% Bupivacaine in conjunction with 0.1 mcg/kg dexamethasone

Outcome Measures

Primary Outcome Measures

  1. Postoperative FLACC scale [for 24 hours after surgery]

    FLACC scale: 0 : relaxed/ comfortable, 1-3 : mild discomfort, 4-6 : moderate discomfort, 7- 10: sever discomfort/ Pain / both,

  2. Postoperative sedation score [for 4 hours after surgery]

    The degree of sedation will be assessed by using a three point sedation scale based on eye opening: - Alert with spontaneous eye opening 0, - Drowsy with eyes only opening in response to speech 1, - Sedated with eyes opening in response to physical stimulation 2,

Secondary Outcome Measures

  1. Heart rate [For 4 hours after induction]

    (beat/min)

  2. Systolic blood pressure [For 4 hours after induction]

    (mmHg)

  3. Postoperative nausea [for 24 hours after surgery]

    As nausea can't be detected in this age group; so we will detect only if vomiting occur or not and number of attacks.

  4. Haematoma formation after surgery [for 24 hours after surgery]

    That will be scored as follows; Yes: there is hematoma formation or No: no hematoma formation

  5. Postoperative vomiting [for 24 hours after surgery]

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Month to 1 Year
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • American society of anesthesiologist (ASA) physical status I or II
Exclusion Criteria:
  • known allergy to any of drugs used

  • coagulopathy

  • any wound or infection related to puncture site

  • major illness

  • failure to gain consent of parents.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mansoura University Childeren Hospital Mansourah DK Egypt 050

Sponsors and Collaborators

  • Mansoura University

Investigators

  • Study Chair: Enas Abd el Motlb, MD, Mansoura University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mansoura University
ClinicalTrials.gov Identifier:
NCT03480607
Other Study ID Numbers:
  • R/17.05.85
First Posted:
Mar 29, 2018
Last Update Posted:
Sep 7, 2020
Last Verified:
Sep 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 7, 2020